Merck & Company, Inc. (new)

74,20 EUR -0,40 (-0,54%)
Bid 73,90 EUR
Ask 74,30 EUR

Premiumpartner

Firmenbeschreibung

Merck & Co. Inc. ist ein forschungsorientiertes, globales Pharmaunternehmen, das ein breites Sortiment an neuartigen Medikamenten, Impfstoffen und biologischen Therapeutika erforscht, entwickelt, produziert und vermarktet. Das Angebot richtet sich vorwiegend an Krankenhäuser, Apotheken, Einzelhändler, Versicherungen, Regierungsverwaltungen oder institutionelle Einrichtungen aus dem Gesundheitswesen. Des Weiteren bietet Merck & Co. nicht-verschreibungspflichtige Medikamente, Produkte für die Fußpflege und Sonnenschutzmittel sowie Gesundheitsprodukte für Tiere an. Dabei bedient sich das Unternehmen der Biotechnologie, der Genforschung und der Gentherapie. Schwerpunkte sind die Behandlung von Allergien, Atemwegserkrankungen, Infektionskrankheiten, Krebs, Herz- und Kreislauferkrankungen, Erkrankungen des zentralen Nervensystems sowie Hautkrankheiten.

KeyData

endOfFinancialYear: 31.12.2024 00:00
stockholderStructure: Vanguard Group Inc (9.94%),Blackrock Inc. (8.79%),State Street Corporation (4.79%),Wellington Management Group, LLP (3.2%),Geode Capital Management, LLC (2.42%),Morgan Stanley (1.75%),FMR, LLC (1.48%),Bank of America Corporation (1.44%),NORGES BANK (1.38%),Northern Trust Corporation (1.24%)
sharesOutstanding: 2526036240.0000
ceo: Robert M. Davis
board: Caroline Litchfield, Sanat Chattopadhyay, Richard R. DeLuca, Jr., Cristal N. Downing, Chirfi Guindo, Betty Larson, Dean Y. Li, Jannie Oosthuizen, Joseph Romanelli, Dave Williams, Jennifer Zachary
supervisoryBoard: Robert M. Davis, Douglas M. Baker, Jr., Mary Ellen Coe, Pamela J. Craig, Thomas H. Glocer, Surendralal L. Karsanbhai, Risa J. Lavizzo-Mourey, Stephen L. Mayo, Paul B. Rothman, Patricia F. Russo, Christine E. Seidman, Inge G. Thulin, Kathy J. Warden
countryID: 20
freeFloat: 83.8400
faceValue: 0.5000
faceValueCurrencyID: 4
faceValueCurrency: USD
sectorName: Pharmazeutische Industrie
industryName: Gesundheitswesen
subsectorName: Pharmazeutische Industrie
country: USA
countryName: USA

Kontakt

phone: +1-732-594-1468
email: investor_relations@merck.com
irWebSite: https://www.merck.com/investor-relations/

Adresse

street: 126 East Lincoln Avenue
city: Rahway, NJ 07065 USA
phone: +1-908-740-4000
webSite: www.merck.com
webcastsWebSite: https://www.merck.com/investor-relations/events-and-presentations/

Finanzen (kurz)

year: 2022 cash: 12694.0000
balanceSheetTotal: 109160.0000 liabilities: 63102.0000
shareCapital: 1788.0000 totalShareholdersEquity: 46058.0000
sales: 59283.0000 incomeBeforeTaxes: 16444.0000
netIncome: 14519.0000 cashFlow: 4606.0000
currencyID: 4 units: 1000000
currency: USD
year: 2023 cash: 6841.0000
balanceSheetTotal: 106675.0000 liabilities: 69040.0000
shareCapital: 1788.0000 totalShareholdersEquity: 37635.0000
sales: 60115.0000 incomeBeforeTaxes: 1889.0000
netIncome: 365.0000 cashFlow: -5864.0000
currencyID: 4 units: 1000000
currency: USD
year: 2024 cash: 13242.0000
balanceSheetTotal: 117106.0000 liabilities: 70734.0000
shareCapital: 1788.0000 totalShareholdersEquity: 46372.0000
sales: 64168.0000 incomeBeforeTaxes: 19936.0000
netIncome: 17117.0000 cashFlow: 6409.0000
currencyID: 4 units: 1000000
currency: USD

Finanzen (kurz)

year: 2022
cash: 12694.0000
balanceSheetTotal: 109160.0000
liabilities: 63102.0000
shareCapital: 1788.0000
totalShareholdersEquity: 46058.0000
sales: 59283.0000
incomeBeforeTaxes: 16444.0000
netIncome: 14519.0000
cashFlow: 4606.0000
currencyID: 4
units: 1000000
currency: USD
year: 2023
cash: 6841.0000
balanceSheetTotal: 106675.0000
liabilities: 69040.0000
shareCapital: 1788.0000
totalShareholdersEquity: 37635.0000
sales: 60115.0000
incomeBeforeTaxes: 1889.0000
netIncome: 365.0000
cashFlow: -5864.0000
currencyID: 4
units: 1000000
currency: USD
year: 2024
cash: 13242.0000
balanceSheetTotal: 117106.0000
liabilities: 70734.0000
shareCapital: 1788.0000
totalShareholdersEquity: 46372.0000
sales: 64168.0000
incomeBeforeTaxes: 19936.0000
netIncome: 17117.0000
cashFlow: 6409.0000
currencyID: 4
units: 1000000
currency: USD

Finanzen (ausführlich)

year: 2023 units: 1000000
balanceSheetTotal: 106675.0000 cash: 6841.0000
currentAssets: 32168.0000 fixedAssets: 74507.0000
liabilities: 25694.0000 totalLiabilitiesEquity: 106675.0000
totalShareholdersEquity: 37635.0000 property: 23051.0000
intangibleAssets: 18011.0000 longTermInvestments: 252.0000
inventories: 6358.0000 accountsReceivable: 10349.0000
accountsPayable: 3922.0000 liabilitiesTotal: 69040.0000
longTermDebt: 33683.0000 shortTermDebt: 1372.0000
minorityInterests: 54.0000 commonStock: 1788.0000
sales: 60115.0000 depreciation: 3844.0000
netIncome: 365.0000 incomeInterest: -781.0000
investments: 30531.0000 incomeTaxes: 1512.0000
costGoodsSold: 16126.0000 grossProfit: 43989.0000
minorityInterestsProfit: 12.0000 cashFlow: 13006.0000
cashFlowInvesting: -14083.0000 cashFlowFinancing: -4810.0000
cashFlowTotal: -5864.0000 accountingStandard: US GAAP
equityRatio: 35.2801 debtEquityRatio: 0.9314
liquidityI: 0.2662 liquidityII: 0.6690
netMargin: 0.6072 grossMargin: 73.1747
cashFlowMargin: 21.6352 ebitMargin: 0.0000
ebitdaMargin: 0.0000 preTaxROE: 5.0193
preTaxROA: 1.7708 roe: 0.9698
roa: 0.3422 netIncomeGrowth: -97.4861
revenuesGrowth: 1.4034 taxExpenseRate: 80.0424
equityTurnover: 1.5973 epsBasic: 0.1400
epsDiluted: 0.1400 epsBasicGrowth: -97.5567
shareCapital: 1788.0000 incomeBeforeTaxes: 1889.0000
priceEarningsRatioCompany: 778.7143 priceCashFlowRatio: 21.2293
dividendYield: 2.7151 bookValuePerShare: 14.8600
marketCap: 276108834925.4400 earningsYield: 0.1284
pegRatio: -7.9822 cashFlowPerShare: 5.1353
netAssetsPerShare: 14.8813 priceBookValueRatio: 7.3365
dividendsPerShare: 2.9600 priceEarningsRatio: 756.4626
netEarningsPerShare: 0.1441 currency: USD
year: 2024 units: 1000000
balanceSheetTotal: 117106.0000 cash: 13242.0000
currentAssets: 38782.0000 fixedAssets: 78324.0000
liabilities: 28420.0000 totalLiabilitiesEquity: 117106.0000
totalShareholdersEquity: 46372.0000 property: 23779.0000
intangibleAssets: 16370.0000 longTermInvestments: 463.0000
inventories: 6109.0000 accountsReceivable: 10278.0000
accountsPayable: 4079.0000 liabilitiesTotal: 70734.0000
longTermDebt: 34462.0000 shortTermDebt: 2649.0000
minorityInterests: 59.0000 commonStock: 1788.0000
sales: 64168.0000 depreciation: 4495.0000
netIncome: 17117.0000 incomeInterest: -24.0000
investments: 17938.0000 incomeTaxes: 2803.0000
costGoodsSold: 15193.0000 grossProfit: 48975.0000
minorityInterestsProfit: 16.0000 cashFlow: 21468.0000
cashFlowInvesting: -7734.0000 cashFlowFinancing: -7032.0000
cashFlowTotal: 6409.0000 accountingStandard: US GAAP
equityRatio: 39.5983 debtEquityRatio: 0.8003
liquidityI: 0.4659 liquidityII: 0.8276
netMargin: 26.6753 grossMargin: 76.3231
cashFlowMargin: 33.4559 ebitMargin: 0.0000
ebitdaMargin: 0.0000 preTaxROE: 42.9915
preTaxROA: 17.0239 roe: 36.9124
roa: 14.6167 netIncomeGrowth: 4589.5890
revenuesGrowth: 6.7421 taxExpenseRate: 14.0600
equityTurnover: 1.3838 epsBasic: 6.7600
epsDiluted: 6.7400 epsBasicGrowth: 4728.5714
shareCapital: 1788.0000 incomeBeforeTaxes: 19936.0000
priceEarningsRatioCompany: 14.7160 priceCashFlowRatio: 11.7053
dividendYield: 3.1363 bookValuePerShare: 18.3576
marketCap: 251290085155.2000 earningsYield: 6.7953
pegRatio: 0.0031 cashFlowPerShare: 8.4987
netAssetsPerShare: 18.3810 priceBookValueRatio: 5.4190
dividendsPerShare: 3.1200 priceEarningsRatio: 14.6807
netEarningsPerShare: 6.7762 currency: USD
year: 2025 priceEarningsRatioCompany: 12.4556
priceCashFlowRatio: 9.9074 dividendYield: 3.7055
bookValuePerShare: 18.3576 marketCap: 212692251408.0000
earningsYield: 8.0285 pegRatio: 0.0026
cashFlowPerShare: 8.4987 netAssetsPerShare: 18.3576
priceBookValueRatio: 4.5867 priceEarningsRatio: 12.4258
netEarningsPerShare: 6.7762 currency: USD

Finanzen (ausführlich)

year: 2023
units: 1000000
balanceSheetTotal: 106675.0000
cash: 6841.0000
currentAssets: 32168.0000
fixedAssets: 74507.0000
liabilities: 25694.0000
totalLiabilitiesEquity: 106675.0000
totalShareholdersEquity: 37635.0000
property: 23051.0000
intangibleAssets: 18011.0000
longTermInvestments: 252.0000
inventories: 6358.0000
accountsReceivable: 10349.0000
accountsPayable: 3922.0000
liabilitiesTotal: 69040.0000
longTermDebt: 33683.0000
shortTermDebt: 1372.0000
minorityInterests: 54.0000
commonStock: 1788.0000
sales: 60115.0000
depreciation: 3844.0000
netIncome: 365.0000
incomeInterest: -781.0000
investments: 30531.0000
incomeTaxes: 1512.0000
costGoodsSold: 16126.0000
grossProfit: 43989.0000
minorityInterestsProfit: 12.0000
cashFlow: 13006.0000
cashFlowInvesting: -14083.0000
cashFlowFinancing: -4810.0000
cashFlowTotal: -5864.0000
accountingStandard: US GAAP
equityRatio: 35.2801
debtEquityRatio: 0.9314
liquidityI: 0.2662
liquidityII: 0.6690
netMargin: 0.6072
grossMargin: 73.1747
cashFlowMargin: 21.6352
ebitMargin: 0.0000
ebitdaMargin: 0.0000
preTaxROE: 5.0193
preTaxROA: 1.7708
roe: 0.9698
roa: 0.3422
netIncomeGrowth: -97.4861
revenuesGrowth: 1.4034
taxExpenseRate: 80.0424
equityTurnover: 1.5973
epsBasic: 0.1400
epsDiluted: 0.1400
epsBasicGrowth: -97.5567
shareCapital: 1788.0000
incomeBeforeTaxes: 1889.0000
priceEarningsRatioCompany: 778.7143
priceCashFlowRatio: 21.2293
dividendYield: 2.7151
bookValuePerShare: 14.8600
marketCap: 276108834925.4400
earningsYield: 0.1284
pegRatio: -7.9822
cashFlowPerShare: 5.1353
netAssetsPerShare: 14.8813
priceBookValueRatio: 7.3365
dividendsPerShare: 2.9600
priceEarningsRatio: 756.4626
netEarningsPerShare: 0.1441
currency: USD
year: 2024
units: 1000000
balanceSheetTotal: 117106.0000
cash: 13242.0000
currentAssets: 38782.0000
fixedAssets: 78324.0000
liabilities: 28420.0000
totalLiabilitiesEquity: 117106.0000
totalShareholdersEquity: 46372.0000
property: 23779.0000
intangibleAssets: 16370.0000
longTermInvestments: 463.0000
inventories: 6109.0000
accountsReceivable: 10278.0000
accountsPayable: 4079.0000
liabilitiesTotal: 70734.0000
longTermDebt: 34462.0000
shortTermDebt: 2649.0000
minorityInterests: 59.0000
commonStock: 1788.0000
sales: 64168.0000
depreciation: 4495.0000
netIncome: 17117.0000
incomeInterest: -24.0000
investments: 17938.0000
incomeTaxes: 2803.0000
costGoodsSold: 15193.0000
grossProfit: 48975.0000
minorityInterestsProfit: 16.0000
cashFlow: 21468.0000
cashFlowInvesting: -7734.0000
cashFlowFinancing: -7032.0000
cashFlowTotal: 6409.0000
accountingStandard: US GAAP
equityRatio: 39.5983
debtEquityRatio: 0.8003
liquidityI: 0.4659
liquidityII: 0.8276
netMargin: 26.6753
grossMargin: 76.3231
cashFlowMargin: 33.4559
ebitMargin: 0.0000
ebitdaMargin: 0.0000
preTaxROE: 42.9915
preTaxROA: 17.0239
roe: 36.9124
roa: 14.6167
netIncomeGrowth: 4589.5890
revenuesGrowth: 6.7421
taxExpenseRate: 14.0600
equityTurnover: 1.3838
epsBasic: 6.7600
epsDiluted: 6.7400
epsBasicGrowth: 4728.5714
shareCapital: 1788.0000
incomeBeforeTaxes: 19936.0000
priceEarningsRatioCompany: 14.7160
priceCashFlowRatio: 11.7053
dividendYield: 3.1363
bookValuePerShare: 18.3576
marketCap: 251290085155.2000
earningsYield: 6.7953
pegRatio: 0.0031
cashFlowPerShare: 8.4987
netAssetsPerShare: 18.3810
priceBookValueRatio: 5.4190
dividendsPerShare: 3.1200
priceEarningsRatio: 14.6807
netEarningsPerShare: 6.7762
currency: USD
year: 2025
priceEarningsRatioCompany: 12.4556
priceCashFlowRatio: 9.9074
dividendYield: 3.7055
bookValuePerShare: 18.3576
marketCap: 212692251408.0000
earningsYield: 8.0285
pegRatio: 0.0026
cashFlowPerShare: 8.4987
netAssetsPerShare: 18.3576
priceBookValueRatio: 4.5867
priceEarningsRatio: 12.4258
netEarningsPerShare: 6.7762
currency: USD